High natural anti-NMDAR1 levels track with milder post-TBI depression in 1,025 Marines

NMDA receptors sit inside the synapse, where they help store new information, and also outside it ^[14]. After a head injury, pathological glutamate release hyperactivates the extrasynaptic ones, and that hyperactivation drives secondary neuronal injury ^[10].

The mouse experiments in the same paper turn on antibody size. Small IgG antibodies fit into the synaptic cleft and impair memory, the pattern seen in anti-NMDAR encephalitis ^[8][15]. Large IgM antibodies do not fit, so they bind the outer, extrasynaptic receptors instead, and in the animals that binding gave long-lasting protection ^[9]. The authors liken the effect to long-acting ketamine ^[11].

The human half of the paper is an association inside a subgroup. The cohort is 1,025 active-duty Marines sampled before and after a seven-month deployment ^[1]. The 25% and 22% figures come only from participants with a lifetime history of TBI, and the announcement does not report how many of the 1,025 that was ^[3]. A quarter of the full cohort is about 256 people ^[17]. The top quartile of the TBI subgroup is smaller than that, and possibly much smaller.

Both percentages describe symptom scores ^[3]. The summary accompanying the paper describes the same result as a 25% lower risk of developing post-deployment depressive symptoms and a 22% lower risk of PTSD symptoms ^[4]. A score and a risk are two different quantities. A group's mean score can fall by a quarter with nobody crossing a diagnostic threshold. The categorical result is the more clinically legible one: high-antibody participants were significantly less likely to report moderate-to-severe depression and used fewer psychiatric medications after returning ^[5]. A 25% reduction in symptom score does not offset the two- to four-fold increase in psychiatric risk after TBI ^[13].

What makes the marker look like a trait is its stability. The antibodies stayed detectable in blood for more than a year ^[7]. There was no association with anxiety, which is a point in the finding's favour, since a marker that moved with every symptom scale would look more like general distress ^[6]. Whatever sets a person's antibody level can travel with other things that affect mood, and an observational cohort cannot separate them, so the causal evidence sits in the mouse experiments ^[9].

For screening, the obstacle is the cut point. Quartiles are defined by this cohort's own distribution, so sitting in the top quarter of these deployed Marines is not a concentration a laboratory can report against ^[3]. About 20 million people a year sustain a concussion or other TBI ^[12], and a usable test would need an assay with a fixed threshold plus replication in people who are not combat-deployed Marines ^[2].